These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36504474)

  • 21. DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis.
    Nasr SH; Vrana JA; Dasari S; Bridoux F; Fidler ME; Kaaki S; Quellard N; Rinsant A; Goujon JM; Sethi S; Fervenza FC; Cornell LD; Said SM; McPhail ED; Herrera Hernandez LP; Grande JP; Hogan MC; Lieske JC; Leung N; Kurtin PJ; Alexander MP
    Kidney Int Rep; 2018 Jan; 3(1):56-64. PubMed ID: 29340314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction.
    Kudose S; Canetta P; Andeen NK; Stokes MB; Batal I; Markowitz GS; D'Agati VD; Santoriello D
    Kidney Int Rep; 2021 Apr; 6(4):936-945. PubMed ID: 33912743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor-Derived ALECT2 Amyloidosis and Recurrent Fibrillary Glomerulonephritis in a Transplant Allograft.
    Nasr SH; Chavez O; Dasari S; Theis JD; Vrana JA; Fatima H; Fu L; Baliga RS; McPhail ED
    Kidney Med; 2021; 3(3):433-437. PubMed ID: 34136788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era.
    L'Imperio V; Barreca A; Vergani B; Sinico RA; Pagni F
    J Nephrol; 2021 Dec; 34(6):2151-2154. PubMed ID: 33905115
    [No Abstract]   [Full Text] [Related]  

  • 25. Congo red-negative amyloidosis-like glomerulopathy: report of a case.
    Sadjadi SA; Sobel HJ
    Am J Kidney Dis; 1987 Mar; 9(3):231-4. PubMed ID: 3826072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal amyloidosis and other fibrillar glomerular diseases.
    Schwartz MM
    Curr Opin Nephrol Hypertens; 1993 Mar; 2(2):238-45. PubMed ID: 7922183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrillary noncongophilic renal and extrarenal deposits: a report on 10 cases.
    Hvala A; Ferluga D; Vizjak A; Koselj-Kajtna M
    Ultrastruct Pathol; 2003; 27(5):341-7. PubMed ID: 14708725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congo red-negative amyloidosis-like glomerulopathy.
    Sturgill BC; Bolton WK; Griffith KM
    Hum Pathol; 1985 Mar; 16(3):220-4. PubMed ID: 2579016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glomerular deposition disease, regarding a case of fibrillary glomerulonephritis].
    Cantillo Jde J; López Rdel P; Andrade RE
    Biomedica; 2009 Dec; 29(4):539-46. PubMed ID: 20440452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotactoid (microtubular) glomerulopathy: an entity distinct from fibrillary glomerulonephritis?
    Alpers CE
    Am J Kidney Dis; 1992 Feb; 19(2):185-91. PubMed ID: 1739104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathology and diagnosis of renal non-AL amyloidosis.
    Sethi S; Theis JD
    J Nephrol; 2018 Jun; 31(3):343-350. PubMed ID: 28828707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgM monoclonal gammopathy with heavy-and-light-chain amyloidosis resembling fibrillary glomerulonephritis determined by tandem mass spectrometry: a case report.
    Adachi M; Kitamura M; Muta K; Maekawa A; Uramatsu T; Tadokoro M; Funakoshi S; Hisano S; Kuwahara N; Shimizu A; Mukae H; Nishino T
    BMC Nephrol; 2020 May; 21(1):195. PubMed ID: 32448180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Polarized Light and Fluorescence Microscopy of Congo Red Stain in the Diagnosis of Renal Amyloidosis.
    Lee AYS; Bayly A; Lin MW
    Lab Med; 2021 Nov; 52(6):574-577. PubMed ID: 33929031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrillary deposits: amyloids and tactoids.
    Looi LM
    Malays J Pathol; 1995 Jun; 17(1):1-10. PubMed ID: 8906998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glomerulopathies with organized monoclonal immunoglobulin deposits].
    Touchard G; Bridoux F; Goujon JM
    Nephrol Ther; 2016 Feb; 12(1):57-65. PubMed ID: 26810049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrillary Glomerulonephritis, DNAJB9, and the Unfolded Protein Response.
    Andeen NK; Kung VL; Robertson J; Gurley SB; Avasare RS; Sitaraman S
    Glomerular Dis; 2022; 2(4):164-175. PubMed ID: 36817290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Posttransplant Fibrillary Glomerulonephritis.
    Ammayappan SK; Rajagopalan A; Rajendran M; Arunachalam J; Prasath A; Durai R; Kurien AA
    Indian J Nephrol; 2023; 33(3):206-208. PubMed ID: 37448907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotoxic stress/p53-induced DNAJB9 inhibits the pro-apoptotic function of p53.
    Lee HJ; Kim JM; Kim KH; Heo JI; Kwak SJ; Han JA
    Cell Death Differ; 2015 Jan; 22(1):86-95. PubMed ID: 25146923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fibrillary glomerulonephritis].
    Dumas De La Roque C; Brocheriou I; Mirouse A; Cacoub P; Le Joncour A
    Rev Med Interne; 2024 May; ():. PubMed ID: 38755072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal amyloidosis associated with extracapillary glomerulonephritis and vasculitis in a patient with inflammatory bowel disease treated with infliximab.
    Hatakeyama T; Komatsuda A; Matsuda A; Togashi M; Maki N; Masai R; Sawada K; Wakui H
    Clin Nephrol; 2008 Sep; 70(3):240-4. PubMed ID: 18793566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.